BMI-1 Autoantibody as a New Potential Biomarker for Cervical Carcinoma
Figure 1
The expression of BMI-1 in cervical carcinoma cell lines and controls.
A. RT-PCR analysis of BMI-1 mRNA in various cervical carcinoma cell lines. B. The ratio of BMI-1 mRNA expression in various cervical carcinoma cell lines. C. Immunoblotting of BMI-1 protein in various cervical carcinoma cell lines. D. Quantification of BMI-1 protein expression in various cervical carcinoma cell lines. The cervical carcinoma cell lines included HeLa, Caski, and SiHa. K562 was used as a positive control. H8 was a normal cervical cell line. GAPDH was used as an internal control.